| Shanghai Neosun Pharmaceutical Technology Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (21) 2095-6531 +86 18116226605 +86 18939712385 | |||
![]() |
neosunpharm@163.com | |||
![]() |
QQ chat | |||
| Chemical manufacturer since 2014 | ||||
| chemBlink standard supplier since 2014 | ||||
| Classification | API >> Antineoplastic agents |
|---|---|
| Name | Tivozanib monohydrochloride monohydrate |
| Synonyms | N-[2-Chloro-4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(5-methyl-3-isoxazolyl)-urea monohydrochloride monohydrate |
| Molecular Structure | ![]() |
| Molecular Formula | C22H19ClN4O5.HCl.H2O |
| Molecular Weight | 509.34 |
| CAS Registry Number | 682745-41-1 |
| EC Number | 885-701-7 |
| SDS | Available |
|---|---|
| Market Analysis Reports |
| List of Reports Available for Tivozanib monohydrochloride monohydrate |